191 related articles for article (PubMed ID: 30910370)
21. Acute Kidney Disease Due to Excessive Vitamin C Ingestion and Remote Roux-en-Y Gastric Bypass Surgery Superimposed on CKD.
Sunkara V; Pelkowski TD; Dreyfus D; Satoskar A
Am J Kidney Dis; 2015 Oct; 66(4):721-4. PubMed ID: 26271145
[TBL] [Abstract][Full Text] [Related]
22. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
McConnell KN; Rolton HA; Modi KS; Macdougall AI
Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
[TBL] [Abstract][Full Text] [Related]
23. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases.
Marangella M; Petrarulo M; Vitale C; Daniele PG; Sammartano S; Cosseddu D; Linari F
Clin Sci (Lond); 1991 Oct; 81(4):483-90. PubMed ID: 1657494
[TBL] [Abstract][Full Text] [Related]
24. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
Plumb TJ; Swee ML; Fillaus JA
Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
[TBL] [Abstract][Full Text] [Related]
25. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
Watts RW; Veall N; Purkiss P
Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
[TBL] [Abstract][Full Text] [Related]
26. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
Ono K
Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
[TBL] [Abstract][Full Text] [Related]
27. Regressive course of oxalate deposition in primary hyperoxaluria after kidney transplantation.
Celik G; Sen S; Sipahi S; Akkin C; Tamsel S; Töz H; Hoscoskun C
Ren Fail; 2010; 32(9):1131-6. PubMed ID: 20863224
[TBL] [Abstract][Full Text] [Related]
28. Long-term complications of systemic oxalosis in children-a retrospective single-center cohort study.
Ben-Shalom E; Cytter-Kuint R; Rinat C; Becker-Cohen R; Tzvi-Behr S; Goichberg J; Peles V; Frishberg Y
Pediatr Nephrol; 2021 Oct; 36(10):3123-3132. PubMed ID: 33651179
[TBL] [Abstract][Full Text] [Related]
29. A CASE OF RETINAL ATHEROSCLEROTIC OXALOSIS DUE TO HYPEROXALURIA IN A PATIENT WITH SHORT GUT SYNDROME.
Lee S; Malbin B; Alfaro C; Syeda S; Lin X
Retin Cases Brief Rep; 2024 Jul; 18(4):529-533. PubMed ID: 37104814
[TBL] [Abstract][Full Text] [Related]
30. Oxalate nephropathy and intravenous vitamin C.
Cossey LN; Rahim F; Larsen CP
Am J Kidney Dis; 2013 Jun; 61(6):1032-5. PubMed ID: 23548555
[TBL] [Abstract][Full Text] [Related]
31. Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure.
Mousson C; Justrabo E; Rifle G; Sgro C; Chalopin JM; Gérard C
Nephron; 1993; 63(1):104-6. PubMed ID: 8446234
[TBL] [Abstract][Full Text] [Related]
32. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.
Ellis SR; Hulton SA; McKiernan PJ; de Ville de Goyet J; Kelly DA
Nephrol Dial Transplant; 2001 Feb; 16(2):348-54. PubMed ID: 11158411
[TBL] [Abstract][Full Text] [Related]
33. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure.
Marangella M; Vitale C; Petrarulo M; Tricerri A; Cerelli E; Cadario A; Barbos MP; Linari F
Kidney Int; 1995 Jul; 48(1):182-7. PubMed ID: 7564076
[TBL] [Abstract][Full Text] [Related]
34. Oxalate kinetics and reversal of the complications after orthotopic liver transplantation in a patient with primary hyperoxalosis type 1 awaiting renal transplantation.
Bastani B; Mistry BM; Nahass GT; Joh J; Dundoo G; Solomon H
Am J Nephrol; 1999; 19(1):64-9. PubMed ID: 10085453
[TBL] [Abstract][Full Text] [Related]
35. [Acute renal failure in a 75-year-old woman with a high-output ileostoma].
Teege S; Wiech T; Steinmetz OM
Internist (Berl); 2017 May; 58(5):507-511. PubMed ID: 28084501
[TBL] [Abstract][Full Text] [Related]
36. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
[TBL] [Abstract][Full Text] [Related]
37. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
[TBL] [Abstract][Full Text] [Related]
38. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
Costello JF; Sadovnic MC; Smith M; Stolarski C
J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
[TBL] [Abstract][Full Text] [Related]
39. Oxalate removal by hemodialysis in end-stage renal disease.
Ramsay AG; Reed RG
Am J Kidney Dis; 1984 Sep; 4(2):123-7. PubMed ID: 6475942
[TBL] [Abstract][Full Text] [Related]
40. Paraplegia as a presentation of primary hyperoxaluria.
Dieudonné Y; Eprinchard L; Léon E; Oswald P; Gressel A; Carre S; Dimitrov Y
CEN Case Rep; 2018 Nov; 7(2):313-315. PubMed ID: 29959618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
